Evaluation of antiviral therapies for coronavirus disease 2019 pneumonia in Shanghai, China
중국 상하이의 코로나바이러스 질환 2019 폐렴에 대한 항바이러스 요법 평가
Article
[키워드] addition
Admission
age
Antiviral
antiviral drug
antiviral drugs
antiviral therapy
Chest computed tomography
Chest CT
China
clinical manifestations
clinical symptom
Clinical symptoms
Computed tomography
coronavirus disease
Coronavirus disease 2019
cough
COVID-19
COVID-19 patients
COVID-19 pneumonia
CT imaging
discharge
enrolled
erythrocyte sedimentation
erythrocyte sedimentation rate
evaluate
evaluated
group
groups
had no
Hospital stay
illness onset
Inclusion
laboratory data
Laboratory results
Laboratory test
Laboratory tests
leukocytes
Liver function
Mild
neutrophil
Neutrophils
no significant difference
no significant differences
Patient
patients with pneumonia
Pneumonia
proportion
regimen
sedimentation rate
Seven
Sex
Shanghai
significant difference
significant differences
Symptom
Symptomatic treatment
therapeutic
therapeutic effect
Treatment
were assessed
with COVID-19
[DOI] 10.1002/jmv.25893 PMC 바로가기 [Article Type] Article
[DOI] 10.1002/jmv.25893 PMC 바로가기 [Article Type] Article